Aggressive surgery for metastatic liver neuroendocrine tumors
Top Cited Papers
- 1 December 2003
- Vol. 134 (6) , 1057-1063
- https://doi.org/10.1016/j.surg.2003.07.025
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumorsArchives of Surgery, 2003
- Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: Outcomes of an aggressive approachSurgery, 2002
- Prospective study of the antitumor efficacy of long‐term octreotide treatment in patients with progressive metastatic gastrinomaCancer, 2002
- Hepatic cytoreduction followed by a novel long-acting somatostatin analog: A paradigm for intractable neuroendocrine tumors metastatic to the liverSurgery, 2001
- Comparison of Surgical Results in Patients With Advanced and Limited Disease With Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison SyndromeAnnals of Surgery, 2001
- Treatment of Neuroendocrine GEP Tumours with Somatostatin AnaloguesDigestion, 2000
- Hepatic neuroendocrine metastases: does intervention alter outcomes?1Journal of the American College of Surgeons, 2000
- Determinants of metastatic rate and survival in patients with zollinger-ellison syndrome: A prospective long-term studyGastroenterology, 1995
- Surgical Management of Carcinoid Tumors: Role of Debulking and Surgery for Patients with Advanced DiseaseDigestion, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958